Quick results achieved with the Adtec SteriPlas

How often do LVAD patients with infection need treatment with the Adtec SteriPlas?

 

We recommend a minimum treatment of twice per week. This applies to both outpatients in day clinics and inpatients who have been admitted into the wards.

 

The treatment time itself is as quick as 3 minutes. During these short minutes, the components of cold plasma quickly bombard the cellular structure of bacteria to create micropores which allows access to the microbial DNA for total destruction. This applies to all forms of bacteria regardless of their resistance profile or if they are protected within biofilm.

 

How quick have patients with LVAD infections healed?

 

Our clinical evidence has shown patients have healed in as quick of two weeks of treatment. These are patients who have failed previous therapeutic attempts with conventional treatment methods.


Promising, consistent and reliable results achieved with the Adtec SteriPlas

 

Whilst Left ventricular assist devices (LVADs) have become essential mechanical pumps for patients who have had end stage heart failures, they are also prone to infections especially with the presence of biofilm that complicates treatment options. Cardiologists often rely on conventional antibiotic therapy but with rising antimicrobial resistance rates, they sometimes offer little to no help in achieving stabilisation.

The strong properties of the Adtec SteriPlas cold plasma has been proven to offer complete stabilisation of the LVAD system by destroying all forms of multi-resistant bacteria present, even if they are protected within biofilm. This is due to the unique cold plasma properties that can travel through the gaps around and down the driveline to reach the site of biofilm. This area would normally have been difficult to treat with conventional therapies such as antimicrobial dressings as they are hard to reach, but the Adtec SteriPlas has shown to travel to these sites with ease due to its remarkable antibacterial gaseous properties.

 

To learn more about our strong collection of clinical evidence, please contact us at info@adtecplasma.com to learn more


We welcome you to our new office

We are excited to introduce you to our new office layout. The renovation works have finally been completed at our new location and all of our staff are now back onsite to continue business as normal. We look forward to welcoming our customers and partners to our new office, as well as to meet you all soon at the upcoming exhibitions and customer meetings we have planned.

 

   


Adtec Healthcare has moved to Twickenham

 

It is official, we have moved!

We are proud to announce that due to our remarkable growth over the years and to serve you better with even more space, we have decided to expand our company and move location to a bigger office. Adtec Europe Ltd and Adtec Healthcare will now be based at the beautiful and leafy area of Twickenham.

Whilst the new office location is under renovation, the majority of our team will again be working from home, but customer visits and meetings will still take place as usual. We look forward to moving into our new office around mid-August once the renovations are completed.

Loyalty from customers like you has fueled our continued growth. Thank you for your ongoing support.


Safe UV and Reactive Species levels only with the Adtec SteriPlas

As a leading medical device company, the crucial balance of safety and clinical efficacy are a top priority. We are always conducting tests to demonstrate the approved safety and reliability of the Adtec SteriPlas but to also learn new ways to improve the use of cold plasma in medicine.

 

Our clinical studies already validate the safety of the Adtec SteriPlas, including its low-level UV and reactive species produced from the cold plasma. These two components are imperative for the physical destruction of bacteria, however, too much of a good thing can also be relatively damaging like that observed with cold plasma jet/pens and battery powered cold plasma devices.

 

Measured across multiple distances, the UV light produced is well below the ICNIRP limit of 30 J/m2 and the reactive species produced are well below the occupational limits set by NIOSH and UK HSE. The Adtec SteriPlas continues to be one of the only cold plasma medical devices that puts patient and user safety first with no reported side effects and promising clinical efficacy from every treatment conducted.

For more information about the Adtec SteriPlas, send us an email at info@adtecplasma.com


Adtec Healthcare prepares for exhibition in July

We are very excited to be exhibiting at the Malvern Diabetic Foot Conference between 7-9th July. This will be our first physical exhibition participation in over a year! Be sure to visit us and see our cold plasma medical device live in action, perfect for the treatment of chronic DFUs infected with biofilm.


E-poster at the EADV 2021 Conference

 

We look forward to supporting Fiona Koch’s e-poster that will be live during the EADV 2021 Spring Symposium tomorrow. Tune in to their website to get full access to her poster, “Efficacy of cold atmospheric plasma versus diclophenac 3% gel in patients with actinic keratoses: a prospective, randomized and rater-blinded study (ACTICAP)”.

 

To learn more about the Adtec SteriPlas’ strong clinical efficacy for the treatment of actinic keratoses, contact us at info@adtecplasma.com


Casopis Lecba ran-page-003

Did you see the Adtec SteriPlas featured in the Czech Society for Wound Healing magazine?


Dr Hokynková from the Department of Burns and Plastic Surgery at Brno Hospital in Czech Republic had published a case study in the magazine to document the efficacy of the Adtec SteriPlas after having tested this on a variety of wounds including pressure ulcers and diabetic foot ulcers.

 

The article validates the SteriPlas’ ability to significantly reduce microbial load within the wound which allows the body to regain control and accelerate healing of stalled wounds. This includes wounds that are already contaminated with biofilm and listed for amputations. A change from the conventional therapies already existing on the market, the Adtec SteriPlas has proven to reverse further deterioration of complicated wounds and allow full healing and stability to be achieved.

 

For a translation of the article or to learn more about our efficacy and treatment options, please email us at info@adtecplasma.com

 


LVAD - Heidelberg publication 2021

 

Congratulations to Dr Kremer and the Cardiology Team at The University Hospital Heidelberg for their new publication, “Follow-Up after Cold Atmospheric Argon Plasma for Wound Management of Driveline Infections - A Promising Strategy”. This publication features the use of our Adtec SteriPlas medical device for the treatment of driveline infections (DLI). The results demonstrate how the safety, reliability and painless treatment from the Adtec SteriPlas can significantly reduce the wound and infection around the DLI, with the opportunity for sustainable freedom from DLI.


The SteriPlas sets foot in the U.S.A.

We are excited to share news of our collaboration with The Southern Illinois University in United States of America. Our Adtec SteriPlas will be used as part of their study to examine the effect of cold plasma on a variety of infection burn model cases in a research laboratory setting. This study aims to help tackle the outbreaks of antimicrobial resistant microorganisms that continues to be an issue for burns cases. We look forward to providing more information and the results as the study progresses.